Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), announced today that it will participate…
LONDON, Sept. 27, 2021 (GLOBE NEWSWIRE) — On 20 August 2021, Tiziana Life Sciences Plc (“Old Tiziana”) announced that it…
NANTES, France, Sept. 27, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that it will host…
PALM BEACH GARDENS, Fla., Sept. 27, 2021 (GLOBE NEWSWIRE) — Accelus, a privately held medical technology company focused on accelerating…
SAN DIEGO, CA, Sept. 27, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical…
OCALA, Fla., Sept. 27, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced the filing of a…
REDWOOD CITY, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting…
Proven commercial leader with broad global experience in building and running commercial organizations and successfully launching products for people with…
Announces Results of Annual Meeting of ShareholdersTORONTO and HOUSTON, Sept. 23, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or…
HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects Results build on data from previous…